Neovasc, a vascular device company, has entered into a distribution agreement with LeMaitre Vascular for Neovasc’s biological vascular strip for use in vascular surgery procedures.
Under the terms of the seven-year agreement, the Burlington, Mass.-based LeMaitre has exclusive rights to market and sell certain sizes of Neovasc’s tissue patch products in the United States and Europe.
Alexei Marko, CEO of Neovasc, said that the performance and handling characteristics of its tissue products make LeMaitre appropriate for a number of vascular applications, including carotid endarterectomy, which should complement LeMaitre’s Pruitt-Inahara carotid shunt line.
The Vancouver, Canada-based Neovasc said its biologic vascular strip is derived from bovine pericardial tissue, a biocompatible and versatile material. The strip is designed for use in carotid endarterectomy, as well as other precision vascular applications.